Animal Models and Helicobacter pylori Infection

S Ansari, Y Yamaoka - Journal of clinical medicine, 2022 - mdpi.com
Helicobacter pylori colonize the gastric mucosa of at least half of the world's population.
Persistent infection is associated with the development of gastritis, peptic ulcer disease, and …

Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation

A Gupta, S Shetty, S Mutalik, K Nandakumar… - Heliyon, 2023 - cell.com
Peptic ulcer disease (PUD) is one of the most prevalent gastro intestinal disorder which
often leads to painful sores in the stomach lining and intestinal bleeding. Untreated …

Scope and Limitations of Current Antibiotic Therapies against Helicobacter pylori: Reviewing Amoxicillin Gastroretentive Formulations

R Grosso, MV de-Paz - Pharmaceutics, 2022 - mdpi.com
Even though general improvement of quality of life has happened around the globe,
statistics show that gastric cancer is still a very serious medical concern in some regions of …

Gastric acid powered micromotors for combined-drug delivery to eradiate helicobacter pylori

Q Song, X Ding, Y Liu, W Liu, J Li, B Wang, Z Gu - Applied Materials Today, 2023 - Elsevier
Helicobacter pylori (H. pylori) infection causes gastric infections and leads to a range of
gastric disorders, even becomes a predisposing factor of stomach cancer. Thus, the search …

[HTML][HTML] Advanced interpenetrating polymer networks for innovative gastroretentive formulations targeting Helicobacter pylori gastric colonization

R Grosso, E Benito, AI Carbajo-Gordillo, MJ Díaz… - European Journal of …, 2024 - Elsevier
The escalating challenges of Helicobacter pylori-induced gastric complications, driven by
rising antibiotic resistance and persistent cancer risks, underscore the demand for …

Leading Paediatric Infectious Diseases—Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions

PN Rampedi, MO Ogunrombi, OA Adeleke - Pharmaceutics, 2024 - mdpi.com
Paediatric infectious diseases contribute significantly to global health challenges.
Conventional therapeutic interventions are not always suitable for children, as they are …

Clarithromycin sustained-release tablet may be an improper therapy for the eradication of Helicobacter pylori

X Zuo, Q Shen, J Luo, Y Wang… - Therapeutic Advances in …, 2024 - journals.sagepub.com
Background: Clarithromycin plays an important role in eradicating Helicobacter pylori (H.
pylori) through quadruple therapy. However, there is limited research on whether different …

Repurposing Disulfiram as an Antifungal Agent: Development of a New Disulfiram Vaginal Mucoadhesive Gel

M Lajarin-Reinares, I Naveira-Souto, M Mallandrich… - Pharmaceutics, 2023 - mdpi.com
Alternative formulations need to be developed to improve the efficacy of treatments
administered via the vaginal route. Mucoadhesive gels with disulfiram, a molecule that was …

[PDF][PDF] Leading Paediatric Infectious Diseases—Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions. Pharmaceutics 2024, 16, 712

PN Rampedi, MO Ogunrombi, OA Adeleke - 2024 - academia.edu
Paediatric infectious diseases contribute significantly to global health challenges.
Conventional therapeutic interventions are not always suitable for children, as they are …